Drug Interaction Study of Safinamide and a BCRP Substrate, Rosuvastatin, Concomitantly Administered to Healthy Volunteers
Latest Information Update: 05 Nov 2021
Price :
$35 *
At a glance
- Drugs Rosuvastatin (Primary) ; Safinamide (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- 17 Jul 2017 New trial record